MedPath

The Banana Exercise Type 1 Diabetes Study

Not Applicable
Not yet recruiting
Conditions
Type 1 Diabetes
Registration Number
NCT06917274
Lead Sponsor
University of Aarhus
Brief Summary

Former and current KADET athletes participate in two controlled training sessions: one with a banana 20 minutes pre-exercise and one without. Tandem Data recorded includes sensor glucose, training details, insulin dosing, and meal intake. Continuous glucose monitoring (CGM) data is assessed. Endpoints include differences in glucose levels, hypoglycemia events (SG \<3.9 mmol/L), and Time in Range during training

Detailed Description

Participants:

Former and current KADET athletes invited via a Facebook group. Previous participants in study projects who have expressed interest in being contacted for future studies.

Protocol:

Participants provide written consent for data collection and use.

Each participant completes two training sessions under controlled conditions, including:

Same training time Standardized pre-training meal timing and insulin corrections Similar intensity and environmental factors If pre-training hypoglycemia occurs, training is rescheduled or corrected with glucose tablets, which are documented.

Study Conditions:

Session 1: Participant eats a banana 20 minutes before training. Session 2: No pre-training food intake.

Tandem Control IQ users (insulin pump) take a microbolus (0.05 IE) before banana intake.

Recorded Data by participant:

Training start and end times Sensor glucose (SG) at start and end of training Training type and intensity (Borg scale, heart rate monitoring) Last insulin dose (meal and correction) Last meal details (content and timing) Banana documentation (photo, weight with peel, ripeness level)

CGM data are also assessed.

Endpoints:

Differences in GCG glucose level Time to hypoglycemia and number of hypoglycemia events (SG \<3.9 mmol/L) on banana vs. non-banana days.

Percentage of Time in Range during training. Additional data is reported as available.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • type 1 diabetes
Exclusion Criteria
  • cardiovascular comorbidity
  • neuropathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
CGM glucoseapproximately 60 minute monitoring period during exercise

CGM glucose Time in Range between 3.9 and 10 mmol/l

Secondary Outcome Measures
NameTimeMethod
Time to hypoglycemiaapproximately 30 to 30 minutes

minutes to hypoglycemia after exercise has begun

Borg scaleBorg scale is assessed approximately 15 minutes after exercise

Level of excaution evaluated on Borg scale from 6-20

© Copyright 2025. All Rights Reserved by MedPath